Exchange: OTC·Updated 05:08 PM EDT
News
all
press releases
Curaleaf’s Takeover Bid Pushes ACB Stock To Hit Its Biggest Single-Day Rally In Nearly 11 Months
Curaleaf announced a cash-and-stock offer that represents a 45% premium to Aurora’s 30-day volume-weighted average price.
Stocktwits
More News
Curaleaf Eyes Aurora Cannabis in Deal That Could Reshape the Global Cannabis Market
The cannabis industry may be on the verge of a major shake-up following today’s takeover bid announcement, which, if completed, could pave the way for the creation of a global cannabis powerhouse.This morning, Curaleaf Holdings Inc. (TSX: CURA) (OTCQX: CURLF) announced its intention to launch a takeover bid for Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), in a move aimed at creating what it believes would be a leading global cannabis platform. The proposed transaction would offer Aurora shareholders implied consideration of US$4.00 per share, consisting of 0.3463 Curaleaf shares ...
AllPennyStocks.com
Curaleaf Holdings, Inc. (CURLF) Q2 Earnings and Revenues Surpass Estimates
Curaleaf Holdings, Inc. (CURLF) delivered earnings and revenue surprises of +125.00% and +2.44%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Has Charles River Laboratories International (CRL) Outpaced Other Medical Stocks This Year?
Here is how Charles River Laboratories (CRL) and Curaleaf Holdings, Inc. (CURLF) have performed compared to their sector so far this year.
Zacks
Verano Advances U.S. Exchange Uplisting Plans: Time to Invest?
VRNO's reverse split and prior U.S. redomestication support potential exchange uplisting plans as the company expands stores and product offerings.
Zacks
Curaleaf Prepares for US Exchange Uplisting: Time to Invest?
CURLF's reverse stock split and Delaware domestication plan signal preparation for a potential U.S. uplisting as revenue and international growth improve.
Zacks
Is Cabaletta Bio (CABA) Stock Outpacing Its Medical Peers This Year?
Here is how Cabaletta Bio, Inc. (CABA) and Curaleaf Holdings, Inc. (CURLF) have performed compared to their sector so far this year.
Zacks
Curaleaf Holdings, Inc. (CURLF) Q1 Earnings and Revenues Top Estimates
Curaleaf Holdings, Inc. (CURLF) delivered earnings and revenue surprises of +220.00% and +2.40%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Schedule III for Some, Not All: Understanding the DOJ's Cannabis Shift
DOJ narrows cannabis reform, shifting select marijuana products to Schedule III while leaving broader federal restrictions intact.
Zacks
Curaleaf Launches Buyback Program: Time to Get Bullish on the Stock?
CURLF's $83M buyback lifts shares, but U.S. pricing pressure and rising losses cloud the outlook despite strong international growth momentum.
Zacks

Advertisement|Remove ads.